Abstract
Preliminary Safety and Clinical Activity in a Phase 1 Study of Blu-285, a Potent, Highly-Selective Inhibitor of KIT D816V in Advanced Systemic Mastocytosis (SM)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have